Treatment of Osteopoross and Metabolic Bone Disorders with Nitric Oxde Substrate And/or Donors Background of the Invention
ثبت نشده
چکیده
Wimalawansa et al., "Nitric Oxide Donor Alleviates Ova riectomy-Induced Bone Loss,” Bone, 18(4):301-304, 1996. Wimalawansa et al., “Replacement Therapy with Nitric Oxide or Nitric Oxide Dornor In Vivo, Maintains the Bone Mass in Rats After Ovariectomy,” World congress On Osteopororis, Abstract No. PTU 759, Amsterdam, May 18–23, 1996. Wimalawansa, “Steroid-Induced Osteoporosis can be Pre vented with Nitric Oxide,” American Society for Bone and Mineral Research, Sep. 7-11, 1996. Yallampalli et al., “Calcitonin Gene-Related Peptide Reverses the Hypertension and Significantly Decreases the Fetal Mortality in Pre-Eclampsia Rats Induced by N-Ni tro-L-Arginine Methyl Ester,” Human Reproduction, 11(4):895–899, 1996.
منابع مشابه
The Role of Nitric Oxide Donors in Wound Healing in Diabetes Mellitus
Introduction: Diabetic foot ulcer is a serious complication of diabetes mellitus; it consists of lesions in the deep tissues associated with neurological disorders and peripheral vascular disease in the lower limbs. Delayed wound healing in diabetes leads to long-term hospitalization and even amputation of distal organs. Diabetes mellitus is associated with decreased nitric oxide bioavailabilit...
متن کاملEfficacy of potassium polycitrate on renal stone and microlitiasis predisposed by metabolic disorders in children less than two years
Background: According to high prevalence of renal stone in children, we evaluated the efficacy of treatment with potassium citrate and its correlation with metabolic disorders in children less than two years of age with renal stone and microlithiasis. Methods: In this cross- sectionaly study, 100 patients (less than 2 years old) with renal stone or microlitiasis were evaluated for metabolic di...
متن کاملTherapeutic Agent or Osteopoross Comprising an Active Ingredient of Quercetin Derivatives Background of the Invention
متن کامل
Endocrine and metabolic disorders in β -thalassemia major patients
Background: Thalassemia is the most common hereditary anemia and beta thalassemia major is its most severe form. Endocrine abnormalities in thalassemia major are common disturbing complications that need prompt management. The purpose of this study was to determine the endocrine disorders and bone mineral density in patients with major -thalassemia in Qazvin, Iran. Methods: In this cross- sect...
متن کاملMetabolic Bone Disease in Very Low-Birth-Weight Neonates
Background: Metabolic bone diseases (MBD), including rickets and osteopenia, are important neonatal complications among preterm infants. This study aimed to determine the prevalence and risk factors of MBD in neonates with very low birth weight (VLBW). Methods: This prospective study was conducted on VLBW infants from January 2012 to July 2013. Inclusion criteria were birth weight of ≤1500 g a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2017